2HRA Stock Overview
Engages in the manufacture and sale of chemical-pharmaceutical raw materials and injection molded precision plastic parts.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 2/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
H&R GmbH & Co. KGaA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €4.71 |
52 Week High | €5.28 |
52 Week Low | €4.22 |
Beta | 0.85 |
11 Month Change | -3.68% |
3 Month Change | -1.88% |
1 Year Change | -9.07% |
33 Year Change | -41.27% |
5 Year Change | -30.84% |
Change since IPO | -35.83% |
Recent News & Updates
Recent updates
Shareholder Returns
2HRA | DE Chemicals | DE Market | |
---|---|---|---|
7D | -2.5% | -1.9% | -0.1% |
1Y | -9.1% | 3.1% | 2.4% |
Return vs Industry: 2HRA underperformed the German Chemicals industry which returned 4.1% over the past year.
Return vs Market: 2HRA underperformed the German Market which returned 2.3% over the past year.
Price Volatility
2HRA volatility | |
---|---|
2HRA Average Weekly Movement | 2.8% |
Chemicals Industry Average Movement | 4.4% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.3% |
10% least volatile stocks in DE Market | 2.6% |
Stable Share Price: 2HRA has not had significant price volatility in the past 3 months.
Volatility Over Time: 2HRA's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1919 | 1,690 | Niels Hansen | www.hur.com |
H&R GmbH & Co. KGaA engages in the manufacture and sale of chemical-pharmaceutical raw materials and injection molded precision plastic parts. It operates in three segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment manufactures and distributes paraffins, white oils, plasticizers, base oils, lubricants, and other crude oil-based specialty products, as well as by-products, such as feedstocks and bunker fuels.
H&R GmbH & Co. KGaA Fundamentals Summary
2HRA fundamental statistics | |
---|---|
Market cap | €179.41m |
Earnings (TTM) | €12.97m |
Revenue (TTM) | €1.35b |
13.8x
P/E Ratio0.1x
P/S RatioIs 2HRA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
2HRA income statement (TTM) | |
---|---|
Revenue | €1.35b |
Cost of Revenue | €1.05b |
Gross Profit | €302.68m |
Other Expenses | €289.70m |
Earnings | €12.97m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 14, 2024
Earnings per share (EPS) | 0.35 |
Gross Margin | 22.41% |
Net Profit Margin | 0.96% |
Debt/Equity Ratio | 37.7% |
How did 2HRA perform over the long term?
See historical performance and comparison